Trust score 8/100
Professor Andrew John Davies
👤 2 years of experience
2,341+
Patients seen
2
Years in practice
13
Publications
1
Languages spoken
About
Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Professor Andrew John Davies
Education & training
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Oncology
Career & appointments
-
2024-09–2025-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 4,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 485 |
| Annual physical exam | 99395 | 275 |
| Vaccination administration | 90471 | 1,859 |
| Minor procedure (skin) | 17110 | 596 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 450.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 6 · i10: 9
-
Validation of clinical scoring in Oncology
DOI: 10.9397/euroclin.2026.0 · PMID: 38476587 · cited by 181
-
Long-term follow-up of Oncology across GB
DOI: 10.4077/euroclin.2025.1 · PMID: 37640225 · cited by 175
-
Validation of clinical scoring in Oncology
DOI: 10.3304/euroclin.2024.2 · PMID: 39009386 · cited by 25
-
Long-term follow-up of Oncology across GB
DOI: 10.1966/euroclin.2023.3 · PMID: 39559839 · cited by 107
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · Southampton · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — Southampton · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2025
- national college of family doctors — Member · Since 2025
- European Union of Medical Specialists (UEMS) — Member · Since 2025
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · andrew.john.davies@euroclinics.example
Location
1 tagPatient reviews
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
